SCHEMBL2614764

SCHEMBL2614764

CC(=O)OC[C@@H]1OC(OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 2/20 0.73
▸ THRB P10828 1/20 0.73
▸ HSD17B10 Q99714 1/20 0.73
▸ CA2 P00918 8/20 0.64
▸ TSHR P16473 1/20 0.58
▸ NR3C1 P04150 1/20 0.58
▸ FYN P06241 1/20 0.58
▸ ADRA2A P08913 1/20 0.58
▸ ADORA3 P0DMS8 1/20 0.58
▸ ADRA2B P18089 1/20 0.58
▸ DRD4 P21917 1/20 0.58
▸ DRD3 P35462 1/20 0.58
▸ CA12 O43570 7/20 0.57
▸ CA1 P00915 6/20 0.57
▸ CA9 Q16790 5/20 0.57
▸ CA4 P22748 2/20 0.53
▸ CA5A P35218 2/20 0.53
▸ CA7 P43166 2/20 0.53
▸ CA5B Q9Y2D0 2/20 0.53
▸ LMNA P02545 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10109449 1.00 CYP2D6 (0.73) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL18392671 1.00 CYP2D6 (0.73) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL16136863 1.00 CYP2D6 (0.73) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL14478545 1.00 CYP2D6 (0.73) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL7152247 1.00 CYP2D6 (0.73) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL23266161 1.00 CYP2D6 (0.73) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL2629591 1.00 CYP2D6 (0.73) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL21945978 1.00 CYP2D6 (0.73) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL22330671 1.00 CYP2D6 (0.73) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL133205 1.00 CYP2D6 (0.73) CYP2D6THRBHSD17B10CA2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163551-B2 Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation SEATTLE GENETICS, INC. (US) 2012-04-24 — — US disclosed
US-20090317869-A1 METHODS AND COMPOSITIONS FOR MAKING ANTIBODIES AND ANTIBODY DERIVATIVES WITH REDUCED CORE FUCOSYLATION SEATTLE GENETICS, INC. (US) 2009-12-24 — — US disclosed
Send feedback